Physician profile
Jason Levine
NPI 1851560312
$6,009.01
in general payments reported to CMS, 2019-2025
30 companies · $719 in 2025
The $719 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,358 · 2020: $294 · 2021: $493 · 2022: $1,392 · 2023: $692 · 2024: $1,062 · 2025: $719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,821 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,821.02 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,157.26 | 2019-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $813.23 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $668.94 | 2019-2022 | |
| Tela Bio, INC. | $516.36 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $324.48 | 2019-2023 | Avance Nerve Graft |
| Aroa Biosurgery Incorporated | $305.99 | 2022-2024 | |
| Musculoskeletal Transplant Foundation INC. | $304.58 | 2019-2025 | |
| Medtronic, INC. | $218.97 | 2022 | |
| Polynovo North America LLC | $209.61 | 2022-2024 | Novosorb Btm |
| Abbvie INC. | $193.62 | 2023-2025 | |
| Davol INC. | $175.00 | 2019-2023 | Phasix Mesh |
| Smith+Nephew, INC. | $145.42 | 2019-2025 | Pico 14, Renasys Touch |
| Sientra, INC. | $131.90 | 2022 | |
| Coopersurgical, INC. | $128.34 | 2019-2025 | Onetrac Lx |
| Kci USA, INC. | $126.81 | 2020-2023 | V.A.C. Veraflo, Prevena, Prevena Restor Bellaform |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $125.00 | 2019 | |
| Acera Surgical, INC. | $121.06 | 2022-2024 | Restrata Wound Matrix |
| Solventum Corporation | $60.05 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Kerecis Limited | $54.03 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Vertical Pharmaceuticals, LLC | $28.57 | 2024 | Dsuvia |
| Organogenesis INC. | $23.15 | 2022 | |
| Motiva USA, LLC | $22.70 | 2025 | |
| Stryker Corporation | $22.16 | 2019 | |
| Acell, INC. | $21.95 | 2019 | |
| Wright Medical Technology, INC. | $20.02 | 2019 | |
| Molnlycke Health Care US, LLC | $19.47 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Endo Pharmaceuticals INC. | $19.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.53 | 2022 | |
| Innovation Technologies INC | $18.21 | 2023 | Irrisept |
| Ovik Health, LLC | $14.34 | 2024 | Coflex Tlc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.